Skip to main content
SpringerLink
Log in

Summary of the dietary approaches to stop hypertension (dash) randomized clinical trial

  • Treatment News
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Conclusion

The DASH diet, which does not include sodium reduction or weight loss, had significant blood-pressure-lowering effects in virtually all subgroups. These effects were particularly striking in African Americans and in those with stage 1 hypertension. This intervention adds to our current nonpharmacologic approaches to control high blood pressure. The DASH diet may be an effective strategy for preventing and treating hypertension in a broad cross-section of the population, including those at high risk for hypertension and its complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157:2413–2446.

    Article  Google Scholar 

  2. National High Blood Pressure Education Program: Working group report on primary prevention of hypertension. Bethesda, MD: National Heart, Lung, and Blood Institute; 1993. [NIH publication no. 93-2669.]

    Google Scholar 

  3. Appel LJ, Moore TJ, Obarzanek E, et al.: The effect of dietary patterns on blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial. N Engl J Med 1997, 336:1117–1124.

    Article  PubMed  CAS  Google Scholar 

  4. Elliott P: Observational studies of salt and blood pressure. Hypertension 1991, 17(suppl I):I3-I8.

    PubMed  CAS  Google Scholar 

  5. Sacks FM, Obarzanek E, Windhauser MM, et al.: Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). Ann Epidemiol 1995, 5:108–118.

    Article  PubMed  CAS  Google Scholar 

  6. Svetkey LP, Simons-Morton D, Vollmer WM, et al.: Effects of dietary patterns on blood pressure. Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999, 159:285–293.

    Article  PubMed  CAS  Google Scholar 

  7. Alaimo C, McDowell MA, Briefel RR, et al.: Dietary intake of vitamins, minerals and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988–91. Advance data from Vital and Health Statistics of the Centers for Disease Control and Prevention. Washington, DC: National Center for Health Statistics; 1994.

    Google Scholar 

  8. Kaplan NM: Treatment of hypertension: drug therapy. In Clinical Hypertension, edn 5. Edited by Kaplan NM. Baltimore: Williams & Wilkins; 1990:185.

    Google Scholar 

  9. Stamler J: Blood pressure and high blood pressure: aspects of risk. Hypertension 1991, 18(suppl I):I95-I107.

    PubMed  CAS  Google Scholar 

  10. Cutler JA, Psaty BM, MacMahon S, Furberg CD: Public health issues in hypertension control: what has been learned from clinical trials. In Hypertension: Pathophysiology, Diagnosis and Management, vol 1, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:253–270.

    Google Scholar 

  11. Center for Nutrition Policy and Promotion Web site. http://www.usda.gov/fcs/cnpp.

  12. Svetkey LP, Sacks FM, Obarzanek E, et al.: The DASH diet, sodium intake and blood pressure trial (DASH-sodium): rationale and design. J Am Diet Assoc 1999, 99(suppl):S96-S104.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Health Research and Portland VA Medical Center, 3710 S.W. U.S. Veterans Hospital Road, P.O. Box 1034, 97207, Portland, OR, USA

    William S. Getchell MD, MPH

  2. Duke University Medical Center, Durham, NC, USA

    Laura P. Svetkey MD, MHS

  3. Johns Hopkins University, Baltimore, MD, USA

    Lawrence J. Appel MD, MPH

  4. Merck Pharmaceuticals, Brigham and Women’s Hospital, West Point, PA, Boston, MA, USA

    Thomas J. Moore MD

  5. Pennington Biomedical Research Center, Baton Rouge, LA, USA

    George A. Bray MD

  6. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

    Eva Obarzanek PhD

Authors
  1. William S. Getchell MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura P. Svetkey MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lawrence J. Appel MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas J. Moore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. George A. Bray MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eva Obarzanek PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Getchell, W.S., Svetkey, L.P., Appel, L.J. et al. Summary of the dietary approaches to stop hypertension (dash) randomized clinical trial. Curr Treat Options Cardio Med 1, 295–298 (1999). https://doi.org/10.1007/s11936-999-0024-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-999-0024-6

Search

Navigation